Supervised walking training in patients with peripheral arterial disease – a literature review
DOI:
https://doi.org/10.6016/ZdravVestn.3483Keywords:
peripheral arterial disease, intermittent claudication, exercise, rehabilitation, risk factorsAbstract
Peripheral arterial disease (PAD) most commonly manifests as intermittent claudication – pain in the calves that arises during walking and subsides at rest. Intermittent claudication significantly decreases walking capacity and the quality of life in patients with PAD. Current guidelines recommend supervised exercise training programmes as initial therapy for patients with PAD. Exercise training helps alleviate symptoms, prolongs the claudication distance (the distance after which the patient needs to stop due to claudication pain), and has systemic effects on the cardiovascular system, as well as favourable metabolic effects, potentially improving survival and management of cardiovascular risk factors. For optimal results, these programs are recommended to last at least 3 months with a frequency of at least 3 times per week. Individual training sessions should ideally last between 30 and 60 minutes. This literature review describes supervised exercise training protocols, which have been shown to improve walking capacity and various physiological parameters in patients with PAD.
Downloads
References
1. Ouriel K. Peripheral arterial disease. Lancet. 2001;358(9289):1257-64.
DOI: 10.1016/S0140-6736(01)06351-6
PMID: 11675083
2. Abdulhannan P, Russell DA, Homer-Vanniasinkam S. Peripheral arterial disease: a literature review. Br Med Bull. 2012;104(1):21-39.
DOI: 10.1093/bmb/lds027
PMID: 23080419
3. Dua A, Lee CJ. Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia. Tech Vasc Interv Radiol. 2016;19(2):91-5.
DOI: 10.1053/j.tvir.2016.04.001
PMID: 27423989
4. McDermott MM, Guralnik JM, Ferrucci L, Tian L, Liu K, Liao Y, et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation. 2008;117(19):2484-91.
DOI: 10.1161/CIRCULATIONAHA.107.736108
PMID: 18458172
5. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996;25(2):282-90.
DOI: 10.1093/ije/25.2.282
PMID: 9119553
6. Kravos A, Bubnič-Sotošek K. Ankle-brachial index screening for peripheral artery disease in asymptomatic patients between 50 and 70 years of age. J Int Med Res. 2009;37(5):1611-9.
DOI: 10.1177/147323000903700540
PMID: 19930870
7. Pabon M, Cheng S, Altin SE, Sethi SS, Nelson MD, Moreau KL, et al. Sex Differences in Peripheral Artery Disease. Circ Res. 2022;130(4):496-511.
DOI: 10.1161/CIRCRESAHA.121.320702
PMID: 35175843
8. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al.; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021.
DOI: 10.1016/j.jacc.2020.11.010
PMID: 33309175
9. Blinc A, Kozak M, Šabovič M, Boc V, Poredoš P, Flis V, et al. Priporočila za odkrivanje in zdravljenje periferne arterijske bolezni. Zdr Vestn. 2017;86(3–4):158-74.
DOI: 10.6016/ZdravVestn.2509
10. McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116(9):1540-50.
DOI: 10.1161/CIRCRESAHA.114.303517
PMID: 25908727
11. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg. 2005;41(4):625-30.
DOI: 10.1016/j.jvs.2005.01.012
PMID: 15874926
12. Poredoš P, Jezovnik MK. Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease? Int J Mol Sci. 2015;16(7):14477-89.
DOI: 10.3390/ijms160714477
PMID: 26121301
13. Blinc A, Kozak M, Šabovič M, Božič Mijovski M, Stegnar M, Poredoš P, et al. Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease. Int Angiol. 2017;36(3):216-27.
DOI: 10.23736/S0392-9590.16.03731-7
PMID: 27332992
14. Santos-Parker JR, LaRocca TJ, Seals DR. Aerobic exercise and other healthy lifestyle factors that influence vascular aging. Adv Physiol Educ. 2014;38(4):296-307.
DOI: 10.1152/advan.00088.2014
PMID: 25434012
15. Novaković M, Jug B, Lenasi H. Clinical impact of exercise in patients with peripheral arterial disease. Vascular. 2017;25(4):412-22.
DOI: 10.1177/1708538116678752
PMID: 28256934
16. Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015;45(2):231-44.
DOI: 10.1007/s40279-014-0261-z
PMID: 25230780
17. Lane R, Harwood A, Watson L, Leng GC; Cochrane Vascular Group. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12(12).
PMID: 29278423
18. Parmenter BJ, Dieberg G, Phipps G, Smart NA. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015;20(1):30-40.
DOI: 10.1177/1358863X14559092
PMID: 25432991
19. Januszek R, Mika P, Konik A, Petriczek T, Nowobilski R, Niżankowski R. Effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease. J Cardiol. 2014;64(2):145-51.
DOI: 10.1016/j.jjcc.2013.12.002
PMID: 24438856
20. Saetre T, Enoksen E, Lyberg T, Stranden E, Jørgensen JJ, Sundhagen JO, et al. Supervised exercise training reduces plasma levels of the endothelial inflammatory markers E-selectin and ICAM-I in patients with peripheral arterial disease. Angiology. 2011;62(4):301-5.
DOI: 10.1177/0003319710385338
PMID: 21474466
21. Novaković M, Krevel B, Rajkovič U, Vižintin Cuderman T, Janša Trontelj K, Fras Z, et al. Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease. J Vasc Surg. 2019;70(1):148-56.
DOI: 10.1016/j.jvs.2018.10.109
PMID: 30922760
22. Hamburg NM, Balady GJ. Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation. 2011;123(1):87-97.
DOI: 10.1161/CIRCULATIONAHA.109.881888
PMID: 21200015
23. Andrade-Lima A, Silva Junior N, Chehuen M, Miyasato R, Souza RW, Leicht AS, et al. Walking Training Improves Systemic and Local Pathophysiological Processes in Intermittent Claudication. Eur J Vasc Endovasc Surg. 2021;61(6):954-63.
DOI: 10.1016/j.ejvs.2021.02.022
PMID: 33875324
24. Joras M, Poredoš P. The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease. Vasc Med. 2008;13(4):255-62.
DOI: 10.1177/1358863X08096347
PMID: 18940901
25. Steven S, Daiber A, Dopheide JF, Münzel T, Espinola-Klein C. Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects. Redox Biol. 2017;12:787-97.
DOI: 10.1016/j.redox.2017.04.017
PMID: 28437655
26. Mika P, Wilk B, Mika A, Marchewka A, Nizankowski R. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication. Eur J Cardiovasc Prev Rehabil. 2011;18(5):754-60.
DOI: 10.1177/1741826710389421
PMID: 21450630
27. Izquierdo-Porrera AM, Gardner AW, Powell CC, Katzel LI. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease. J Vasc Surg. 2000;31(4):670-7.
DOI: 10.1067/mva.2000.104422
PMID: 10753274
28. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345(12):892-902.
DOI: 10.1056/NEJMra001529
PMID: 11565523
29. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2001(1).
PMID: 11279730
30. Menêses AL, Ritti-Dias RM, Parmenter B, Golledge J, Askew CD. Combined Lower Limb Revascularisation and Supervised Exercise Training for Patients with Peripheral Arterial Disease: A Systematic Review of Randomised Controlled Trials. Sports Med. 2017;47(5):987-1002.
DOI: 10.1007/s40279-016-0635-5
PMID: 27730569
31. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et al.; Mimic Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg. 2008;36(6):680-8.
DOI: 10.1016/j.ejvs.2008.10.007
PMID: 19022184
32. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686-725.
DOI: 10.1161/CIR.0000000000000470
PMID: 27840332
33. Aboyans V, Ricco JB, Bartelink ML, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral artery diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). Eur Heart J. 2018;39(9):763-816.
DOI: 10.1093/eurheartj/ehx095
PMID: 28886620
34. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65(10):999-1009.
DOI: 10.1016/j.jacc.2014.12.043
PMID: 25766947
35. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg. 2008;48(6):1472-80.
DOI: 10.1016/j.jvs.2008.06.016
PMID: 18771879
36. Fokkenrood HJ, Scheltinga MR, Koelemay MJ, Breek JC, Hasaart F, Vahl AC, et al. Significant savings with a stepped care model for treatment of patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2014;48(4):423-9.
DOI: 10.1016/j.ejvs.2014.04.020
PMID: 24951374
37. Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J. Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease. Vasc Health Risk Manag. 2012;8:225-32.
DOI: 10.2147/VHRM.S30056
PMID: 22566743
38. Gibellini R, Fanello M, Bardile AF, Salerno M, Aloi T. Exercise training in intermittent claudication. Int Angiol. 2000;19(1):8-13.
PMID: 10853679
39. Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR, et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc. 2001;49(6):755-62.
DOI: 10.1046/j.1532-5415.2001.49152.x
PMID: 11454114
40. Crowther RG, Spinks WL, Leicht AS, Sangla K, Quigley F, Golledge J. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg. 2008;47(2):303-9.
DOI: 10.1016/j.jvs.2007.10.038
PMID: 18241753
41. Gardner AW, Killewich LA, Montgomery PS, Katzel LI. Response to exercise rehabilitation in smoking and nonsmoking patients with intermittent claudication. J Vasc Surg. 2004;39(3):531-8.
DOI: 10.1016/j.jvs.2003.08.037
PMID: 14981444
42. Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg. 2005;42(4):702-9.
DOI: 10.1016/j.jvs.2005.05.049
PMID: 16242558
43. Leicht AS, Crowther RG, Golledge J. Influence of peripheral arterial disease and supervised walking on heart rate variability. J Vasc Surg. 2011;54(5):1352-9.
DOI: 10.1016/j.jvs.2011.05.027
PMID: 21784603
44. Hodges LD, Sandercock GR, Das SK, Brodie DA. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease. Clin Physiol Funct Imaging. 2008;28(1):32-7.
DOI: 10.1111/j.1475-097X.2007.00770.x
PMID: 18005078
45. Gardner AW, Katzel LI, Sorkin JD, Killewich LA, Ryan A, Flinn WR, et al. Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication. J Gerontol A Biol Sci Med Sci. 2000;55(10):M570-7.
DOI: 10.1093/gerona/55.10.M570
PMID: 11034229
46. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol. 2001;87(3):324-9.
DOI: 10.1016/S0002-9149(00)01367-9
PMID: 11165969
47. Gardner AW, Montgomery PS, Parker DE. Optimal exercise program length for patients with claudication. J Vasc Surg. 2012;55(5):1346-54.
DOI: 10.1016/j.jvs.2011.11.123
PMID: 22459748
48. Nowak WN, Mika P, Nowobilski R, Kusinska K, Bukowska-Strakova K, Nizankowski R, et al. Exercise training in intermittent claudication: effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells. Thromb Haemost. 2012;108(5):824-31.
PMID: 22955572
49. Mika P, Konik A, Januszek R, Petriczek T, Mika A, Nowobilski R, et al. Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. Int J Cardiol. 2013;168(2):838-42.
DOI: 10.1016/j.ijcard.2012.10.003
PMID: 23117015
50. Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Rev Esp Cardiol (Engl Ed). 2022;75(5):429.
DOI: 10.1016/j.rec.2022.04.003
PMID: 35525570
51. Schlager O, Giurgea A, Schuhfried O, Seidinger D, Hammer A, Gröger M, et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial. Atherosclerosis. 2011;217(1):240-8.
DOI: 10.1016/j.atherosclerosis.2011.03.018
PMID: 21481871
52. Schlager O, Hammer A, Giurgea A, Schuhfried O, Fialka-Moser V, Gschwandtner M, et al. Impact of exercise training on inflammation and platelet activation in patients with intermittent claudication. Swiss Med Wkly. 2012;142:w13623.
PMID: 22893497
53. Cucato GG, Chehuen MR, Costa LA, Ritti-Dias RM, Wolosker N, Saxton JM, et al. Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication. Clinics (São Paulo). 2013;68(7):974-8.
DOI: 10.6061/clinics/2013(07)14
PMID: 23917662
54. Bronas UG, Hirsch AT, Murphy T, Badenhop D, Collins TC, Ehrman JK, et al.; CLEVER Research Group. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study. Vasc Med. 2009;14(4):313-21.
DOI: 10.1177/1358863X09102295
PMID: 19808716
55. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, et al.; CLEVER Study Investigators. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130-9.
DOI: 10.1161/CIRCULATIONAHA.111.075770
PMID: 22090168
56. Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis. 2011;218(1):1-12.
DOI: 10.1016/j.atherosclerosis.2011.04.024
PMID: 21601857
57. Jansen SC, Abaraogu UO, Lauret GJ, Fakhry F, Fokkenrood HJ, Teijink JA. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev. 2020;8(8).
PMID: 32829481
58. Harwood AE, Smith GE, Cayton T, Broadbent E, Chetter IC. A systematic review for the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vasc Surg. 2016;34:280-9.
DOI: 10.1016/j.avsg.2016.02.009
PMID: 27126713
59. Fokkenrood HJ, Bendermacher BL, Lauret GJ, Willigendael EM, Prins MH, Teijink JA. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2013;8(8).
DOI: 10.1002/14651858.CD005263.pub3
PMID: 23970372
60. Vemulapalli S, Dolor RJ, Hasselblad V, Schmit K, Banks A, Heidenfelder B, et al. Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis. Am Heart J. 2015;169(6):924-937.e3.
DOI: 10.1016/j.ahj.2015.03.009
PMID: 26027632
61. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011;123(5):491-8.
DOI: 10.1161/CIRCULATIONAHA.110.963066
PMID: 21262997
62. Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2014;3(5):e001107.
DOI: 10.1161/JAHA.114.001107
PMID: 25237048
63. McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, et al. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310(1):57-65.
DOI: 10.1001/jama.2013.7231
PMID: 23821089
64. McDermott MM, Guralnik JM, Criqui MH, Ferrucci L, Zhao L, Liu K, et al. Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc. 2014;3(3):e000711.
DOI: 10.1161/JAHA.113.000711
PMID: 24850615
65. Poredoš P, Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology. 2007;58(3):309-15.
DOI: 10.1177/0003319707302494
PMID: 17626985
66. Lackland DT, Voeks JH. Metabolic syndrome and hypertension: regular exercise as part of lifestyle management. Curr Hypertens Rep. 2014;16(11):492.
DOI: 10.1007/s11906-014-0492-2
PMID: 25190022
67. Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, et al. Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2015;4(7):e002014.
DOI: 10.1161/JAHA.115.002014
PMID: 26116691
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
